News headlines about Envision Healthcare (NYSE:EVHC) have been trending positive on Thursday, according to Alpha One. The research firm, a unit of Accern, scores the sentiment of media coverage by monitoring more than 20 million news and blog sources in real time. Alpha One ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Envision Healthcare earned a daily sentiment score of 0.37 on Alpha One’s scale. Alpha One also gave headlines about the company an impact score of 66 out of 100, meaning that recent media coverage is likely to have an effect on the stock’s share price in the next several days.
Here are some of the news headlines that may have effected Alpha One Sentiment’s rankings:
- Brokerages Anticipate Envision Healthcare Co. (EVHC) Will Post Earnings of $0.71 Per Share (americanbankingnews.com)
- Envision Healthcare Co. (EVHC) Earns “Buy” Rating from Canaccord Genuity (americanbankingnews.com)
- Envision Healthcare Sets Earnings Release and Conference Call Dates for First-Quarter 2017 Results (finance.yahoo.com)
- Envision Healthcare (EVHC) Earns News Sentiment Score of 0.37 (americanbankingnews.com)
- Envision Healthcare Co. (EVHC) Given Average Rating of “Buy” by Analysts (americanbankingnews.com)
A number of research firms have weighed in on EVHC. Cantor Fitzgerald reiterated a “buy” rating and issued a $80.00 target price on shares of Envision Healthcare in a research note on Thursday, April 6th. Jefferies Group LLC reiterated a “buy” rating and issued a $82.00 target price (down from $90.00) on shares of Envision Healthcare in a research note on Wednesday, March 1st. Canaccord Genuity reiterated a “buy” rating and issued a $86.00 target price on shares of Envision Healthcare in a research note on Tuesday. Royal Bank of Canada dropped their target price on shares of Envision Healthcare from $87.00 to $80.00 and set an “outperform” rating on the stock in a research note on Wednesday, March 1st. Finally, Zacks Investment Research upgraded shares of Envision Healthcare from a “hold” rating to a “buy” rating and set a $76.00 target price on the stock in a research note on Wednesday, February 1st. One analyst has rated the stock with a sell rating, three have given a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. Envision Healthcare presently has an average rating of “Buy” and an average price target of $70.44.
Envision Healthcare (NYSE:EVHC) traded down 3.65% during mid-day trading on Thursday, hitting $55.36. 4,855,307 shares of the stock traded hands. The company’s 50 day moving average price is $62.64 and its 200-day moving average price is $52.19. Envision Healthcare has a 1-year low of $53.12 and a 1-year high of $83.27. The stock’s market cap is $6.43 billion.
Envision Healthcare (NYSE:EVHC) last announced its earnings results on Tuesday, February 28th. The company reported $1.08 EPS for the quarter, missing the Zacks’ consensus estimate of $1.20 by $0.12. The firm earned $1.39 billion during the quarter, compared to the consensus estimate of $1.41 billion. Envision Healthcare had a return on equity of 8.05% and a net margin of 6.06%. The business’s revenue for the quarter was up 97.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.07 earnings per share. Analysts predict that Envision Healthcare will post $1.40 earnings per share for the current year.
In other Envision Healthcare news, insider Robert Jon Coward sold 1,500 shares of the business’s stock in a transaction dated Monday, April 3rd. The shares were sold at an average price of $61.34, for a total value of $92,010.00. Following the completion of the transaction, the insider now directly owns 115,863 shares in the company, valued at $7,107,036.42. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 2.30% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Envision Healthcare (EVHC) Given Daily Coverage Optimism Rating of 0.37” was originally published by WKRB News and is the property of of WKRB News. If you are accessing this report on another domain, it was illegally stolen and republished in violation of international copyright legislation. The correct version of this report can be read at http://www.wkrb13.com/markets/2065679/envision-healthcare-evhc-given-daily-coverage-optimism-rating-of-0-37.html.
About Envision Healthcare
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
This story was originally published by WKRB News (http://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://www.wkrb13.com/markets/2065679/envision-healthcare-evhc-given-daily-coverage-optimism-rating-of-0-37.html
Receive News & Ratings for Envision Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Co. and related companies with MarketBeat.com's FREE daily email newsletter.